Micardis

   
Google
 
Web NewDrugInformation.com

Micardis


Drug - Micardis
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Telmisartan
Multiple ingredients are in alphabetical order.

Strength - 40MG
The potency of the active ingredient(s), Telmisartan. May repeat for multiple part products.

Applicant - BOEHRINGER INGELHEIM
The firm name holding legal responsibility for Micardis. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020850
The FDA assigned number to Micardis. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Micardis. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 10, 1998
The date Micardis was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Micardis. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Micardis is in. Format is RX, OTC, DISCN.

Applicant Full Name - Boehringer Ingelheim
The full name of the firm holding legal responsibility for the new application of Micardis.

Micardis